UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies

Breast cancer research and treatment, 2020-06, Vol.181 (3), p.553-560

2020

Volltextzugriff (PDF)

Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ

British journal of surgery, 2020-01, Vol.107 (1), p.96-102

2020

Volltextzugriff (PDF)

A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)

European journal of cancer (1990), 2018-05, Vol.94, p.79-86

2018

Volltextzugriff (PDF)

Loss‐of‐function mutations in filaggrin gene and malignant melanoma: a case–control study

Journal of the European Academy of Dermatology and Venereology, 2018-02, Vol.32 (2), p.242-244

2018

Volltextzugriff (PDF)

Filaggrin loss‐of‐function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross‐sectional studies

Journal of the European Academy of Dermatology and Venereology, 2017-06, Vol.31 (6), p.1038-1043

2017

Volltextzugriff (PDF)

Individuals with complete filaggrin deficiency may have an increased risk of squamous cell carcinoma

British journal of dermatology (1951), 2014-06, Vol.170 (6), p.1380-1381

2014

Volltextzugriff (PDF)

16 Prognostic Significance of Axillary Lymph Node Dissection in Breast Cancer Patients with Micrometastases or Isolated Tumor Cells in Sentinel Nodes – a Nationwide Study

European journal of cancer (1990), 2012-03, Vol.48, p.S45-S45

2012

Volltextzugriff (PDF)

5014 ORAL High Risk of Non-sentinel Node Metastases in a Group of Breast Cancer Patients With Micrometastases in the Sentinel Node

European journal of cancer (1990), 2011, Vol.47, p.S334-S334

2011

Volltextzugriff (PDF)

Schrödinger Operators, Aarhus 1985: Lectures Given in Aarhus, October 2-4 1985

Balslev, Erik

1986 edition., 2006

Volltextzugriff (PDF)

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7483-7490

2005

Volltextzugriff (PDF)

Risk factors for sentinel node metastases in patients with ductal carcinoma in situ in the breast

European journal of cancer (1990), 2018-04, Vol.92, p.S64

2018

Volltextzugriff (PDF)

241 (PB-036) - Risk factors for sentinel node metastases in patients with ductal carcinoma in situ in the breast

European journal of cancer (1990), 2018-04, Vol.92, p.S64-S64

2018

Volltextzugriff (PDF)

536 (PB-169) - Histopathologic characteristics in synchronous bilateral breast cancer patients: A nationwide Danish cohort study from 1999–2015

European journal of cancer (1990), 2018-04, Vol.92, p.S157-S157

2018

Volltextzugriff (PDF)

Histopathologic characteristics in synchronous bilateral breast cancer patients: A nationwide Danish cohort study from 1999–2015

European journal of cancer (1990), 2018-04, Vol.92, p.S157

2018

Volltextzugriff (PDF)

460 Gemcitabine, carboplatin and paclitaxel as neoadjuvant combination chemotherapy in patients with locally advanced (stage III) or inflammatory breast cancer – a non-anthracycline alternative

European journal of cancer supplements, 2010, Vol.8 (3), p.193-193

2010

Volltextzugriff (PDF)

3N Stage migration after introduction of sentinel lymph node dissection in breast cancer treatment in Denmark: a nationwide study

European journal of cancer supplements, 2010, Vol.8 (3), p.53-54

2010

Volltextzugriff (PDF)

Abstract P2-10-02: Basal biomarkers nestin and INPP4b predict gemcitabine benefit in metastatic breast cancer: Results from the phase III SBG0102 clinical trial

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-10-02

2018

Volltextzugriff (PDF)

Abstract S1-08: High risk premenopausal luminal A breast cancer patients derive no benefit from adjuvant chemotherapy: Results from DBCG77B randomized trial

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S1-S1-08

2016

Volltextzugriff (PDF)

On the relative distribution of eigenvalues of exceptional Hecke operators and automorphic Laplacians

St. Petersburg mathematical journal, 2006-02, Vol.17 (1), p.1-37

2006

Volltextzugriff (PDF)

Abstract S6-03: DBCG 07-READ: A randomized phase III trial comparing six cycles of docetaxel and cyclophosphamide (DC) to three cycles of epirubicin and cyclophosphamide followed by three cycles of docetaxel (EC-D) in patients with early breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.S6-S6-03

2017

Volltextzugriff (PDF)

Crohn's disease presenting as a breast abscess: A case report

Journal of the European Academy of Dermatology and Venereology, 2001-07, Vol.15 (4), p.343-345

2001

Volltextzugriff (PDF)

Treatment of perforating collagenosis of diabetes and renal failure with allopurinol

Clinical and experimental dermatology, 2000-11, Vol.25 (8), p.615-616

2000

Volltextzugriff (PDF)

Vasculitis occurring during leflunomide therapy

Dermatology (Basel), 2001-01, Vol.203 (3), p.258-259

2001

Volltextzugriff (PDF)

Is 0.6T Magnetic Resonance Mammography Adequate in the Detection of Breast Cancer?

Acta radiologica (1987), 2006-06, Vol.47 (5), p.446-453

2006

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(221)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies

Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ

A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)

Loss‐of‐function mutations in filaggrin gene and malignant melanoma: a case–control study

Filaggrin loss‐of‐function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross‐sectional studies

Individuals with complete filaggrin deficiency may have an increased risk of squamous cell carcinoma

16 Prognostic Significance of Axillary Lymph Node Dissection in Breast Cancer Patients with Micrometastases or Isolated Tumor Cells in Sentinel Nodes – a Nationwide Study

5014 ORAL High Risk of Non-sentinel Node Metastases in a Group of Breast Cancer Patients With Micrometastases in the Sentinel Node

Schrödinger Operators, Aarhus 1985: Lectures Given in Aarhus, October 2-4 1985

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

Risk factors for sentinel node metastases in patients with ductal carcinoma in situ in the breast

241 (PB-036) - Risk factors for sentinel node metastases in patients with ductal carcinoma in situ in the breast

536 (PB-169) - Histopathologic characteristics in synchronous bilateral breast cancer patients: A nationwide Danish cohort study from 1999–2015

Histopathologic characteristics in synchronous bilateral breast cancer patients: A nationwide Danish cohort study from 1999–2015

460 Gemcitabine, carboplatin and paclitaxel as neoadjuvant combination chemotherapy in patients with locally advanced (stage III) or inflammatory breast cancer – a non-anthracycline alternative

3N Stage migration after introduction of sentinel lymph node dissection in breast cancer treatment in Denmark: a nationwide study

Abstract P2-10-02: Basal biomarkers nestin and INPP4b predict gemcitabine benefit in metastatic breast cancer: Results from the phase III SBG0102 clinical trial

Abstract S1-08: High risk premenopausal luminal A breast cancer patients derive no benefit from adjuvant chemotherapy: Results from DBCG77B randomized trial

On the relative distribution of eigenvalues of exceptional Hecke operators and automorphic Laplacians

Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers

Abstract S6-03: DBCG 07-READ: A randomized phase III trial comparing six cycles of docetaxel and cyclophosphamide (DC) to three cycles of epirubicin and cyclophosphamide followed by three cycles of docetaxel (EC-D) in patients with early breast cancer

Crohn's disease presenting as a breast abscess: A case report

Treatment of perforating collagenosis of diabetes and renal failure with allopurinol

Vasculitis occurring during leflunomide therapy

Is 0.6T Magnetic Resonance Mammography Adequate in the Detection of Breast Cancer?

Suchergebnisse filtern